<DOC>
	<DOC>NCT01854983</DOC>
	<brief_summary>Clinical Trial to access Significance of fluorescence colposcopy with autofluorescence imaging for the screening of cervical cancer</brief_summary>
	<brief_title>Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer</brief_title>
	<detailed_description>1. Perform pelvic vaginal exam of the subjective to know symptom, illness history, physical exam and basal state before fluorescence colposcopy. 2. Observe acetowhite epithelium and perform biopsy at suspicious lesion during fluorescence colposcopy. 3. Perform fluorescence colposcopy again after biopsy and confirm extraordinary reaction. 4. After 1~2weeks follow up the subjective at opd and confirm biopsy result.</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1. age : 2065 years 2. abnormal cervical papanicolaou smear , no other specific cervical disease 3. subject to colposcopic biopsy or LEEP 4. signed voluntarily to informed concents with full knowledge after explanation abot objective, method, contents 1. pregnant women 2. porphyria 3. severe cervical bleeding 4. genital chlamydia, gonorrhea infection 5. other drug user with possible interaction (e.g. photosensitizer) 6. no informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>fluorescence colposcopy</keyword>
	<keyword>cervical cancer</keyword>
</DOC>